Mucormycosis, commonly referred to as black fungus, is a formidable fungal infection caused by mucormycetes molds. It predominantly afflicts individuals with compromised immune systems, including those with uncontrolled diabetes, transplant recipients, or cancer patients undergoing chemotherapy. Within the realm of ophthalmology, mucormycosis poses significant risks as it can invade the orbit, sinuses, and adjacent tissues. Symptoms range from severe headaches and facial swelling to potential vision loss, particularly when the infection reaches the orbital region or causes cavernous sinus thrombosis. Prompt diagnosis is critical for effective treatment, typically involving aggressive antifungal therapy like amphotericin B and surgical intervention to excise infected tissue. Prevention strategies emphasize managing underlying health conditions and maintaining rigorous hygiene practices, especially in healthcare settings. Heightened awareness among medical professionals is crucial for early detection and improved outcomes in cases of ocular mucormycosis.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom